Overview

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Status:
Terminated
Trial end date:
2017-11-30
Target enrollment:
Participant gender:
Summary
This study is a multi-center, open-label safety study assessing long-term somavaratan administration.
Phase:
Phase 3
Details
Lead Sponsor:
Versartis Inc.
Treatments:
Hormones